Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Vir Biotechnology Inc., 3 years.
Vir Biotechnology Inc.
Director
Alnylam Pharmaceuticals Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 10, 2026 | Alnylam Pharmaceuticals Inc. | Open-market purchase | +1,600 | $152.25 | $243,600 |
| May 27, 2026 | Vir Biotechnology Inc. | Grant or award | +8,000 | — | — |
| May 20, 2026 | Alnylam Pharmaceuticals Inc. | Grant or award | +671 | — | — |
| May 30, 2025 | Vir Biotechnology Inc. | Grant or award | +8,000 | — | — |
| May 8, 2025 | Alnylam Pharmaceuticals Inc. | Grant or award | +775 | — | — |
| May 30, 2024 | Vir Biotechnology Inc. | Grant or award | +8,000 | — | — |
| May 22, 2023 | Vir Biotechnology Inc. | Grant or award | +6,027 | — | — |
| Mar 1, 2023 | Vir Biotechnology Inc. | Open-market purchase | +2,500 | $22.73 | $56,825 |
| Jan 5, 2023 | Vir Biotechnology Inc. | Open-market purchase | +2,500 | $24.96 | $62,400 |
| Jan 4, 2023 | Vir Biotechnology Inc. | Open-market purchase | +2,500 | $25.25 | $63,125 |
| Jan 3, 2023 | Vir Biotechnology Inc. | Open-market purchase | +2,500 | $25.60 | $64,000 |
Questions about Charles Elliott Sigal
What boards is Charles Elliott Sigal on?
Charles Elliott Sigal sits on the boards of Alnylam Pharmaceuticals Inc. and Vir Biotechnology Inc.
How long has Charles Elliott Sigal served on boards?
Our records show at least 7 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.